Claraphi Advisory Network, LLC Gilead Sciences, Inc. Transaction History

Claraphi Advisory Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $204,805 - $257,507	-3,298 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $35,084 - $40,740	-485 Reduced 12.82%	3,298 $254,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $236,929 - $303,472	3,783 New	3,783 $283,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $201,407 - $222,318	-3,222 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$61.87 - $69.38 $199,345 - $223,542	3,222 New	3,222 $218,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.